Atorvastatin ameliorates diabetic cardiomyopathy by enhancing Mzb1-mediated mitigation of oxidative stress and mitochondrial defects.
- DOI
- 10.1016/j.lfs.2026.124596
- Published
- 2026 Oct 1
- Container
- Life sciences
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lfs.2026.124596,
title = {Atorvastatin ameliorates diabetic cardiomyopathy by enhancing Mzb1-mediated mitigation of oxidative stress and mitochondrial defects.},
author = {Gu J and Sun J and Wang X and Zhang Q and Liu Y and Xu Q and Gao J and Li R and Zhen Y and Zhang L and Zhou MS},
year = {2026},
journal = {Life sciences},
doi = {10.1016/j.lfs.2026.124596},
url = {https://doi.org/10.1016/j.lfs.2026.124596}
}RIS
TY - JOUR TI - Atorvastatin ameliorates diabetic cardiomyopathy by enhancing Mzb1-mediated mitigation of oxidative stress and mitochondrial defects. AU - Gu J AU - Sun J AU - Wang X AU - Zhang Q AU - Liu Y AU - Xu Q AU - Gao J AU - Li R AU - Zhen Y AU - Zhang L AU - Zhou MS PY - 2026 JO - Life sciences DO - 10.1016/j.lfs.2026.124596 UR - https://doi.org/10.1016/j.lfs.2026.124596 ER -
APA
J, G., J, S., X, W., Q, Z., Y, L., Q, X., J, G., R, L., Y, Z., L, Z., & MS, Z. (2026). Atorvastatin ameliorates diabetic cardiomyopathy by enhancing Mzb1-mediated mitigation of oxidative stress and mitochondrial defects.. Life sciences. https://doi.org/10.1016/j.lfs.2026.124596
Source records
- pubmed · retrieved 2026-09-27T00:19:01.833Z
- europe-pmc · retrieved 2026-09-27T00:19:01.839Z